Wang Stephen L, Sze Daniel Y, Busque Stephan, Razavi Mahmood K, Kee Stephen T, Frisoli Joan K, Dake Michael D
Division of Vascular and Interventional Radiology, Stanford University Medical Center, H3646, 300 Pasteur Dr, Stanford, CA 94305-5642, USA.
Radiology. 2005 Jul;236(1):352-9. doi: 10.1148/radiol.2361040327. Epub 2005 Jun 13.
To evaluate retrospectively the endovascular management of hepatic venous outflow obstruction after piggyback orthotopic liver transplantation.
The study was performed with the approval and under the guidelines of the institutional review board and complied with the Health Insurance Portability and Accountability Act. Informed consent from patients was not required by the institutional review board for this retrospective study. From 1995 to 2003, 13 patients (eight male, five female), including 12 adults and one adolescent (age range, 14-67 years; median age, 52 years), underwent endovascular treatment of hepatic venous outflow obstruction after piggyback orthotopic liver transplantation. Patients gave informed consent for all procedures. Eleven patients received whole livers, and two received living-related donor right liver lobes. Four underwent repeat piggyback orthotopic liver transplantation prior to intervention. Primary stent placement was performed in 12 patients. One patient refused primary stent placement and chose venoplasty alone, but required a stent 5 months later. Short balloon-expandable stents (mean diameter, 14.6 mm +/- 1.1 [standard deviation]) were used to minimize jailing of branch vessels and to resist recoil. Pre- and post-procedural pressure gradients were measured. Follow-up included venography, cross-sectional imaging, and laboratory tests. The Wilcoxon signed rank test or the sign test was performed to compare pre- and post-procedural pressure gradients, body weights, and laboratory values.
Technical success (pressure gradient < or = 3 mm Hg) was achieved in 13 of 13 patients, and clinical success, in 12 of 13. Mean pre- and post-procedural pressure gradients were 13.0 mm Hg +/- 1.4 and 0.8 mm Hg +/- 0.3. Mean interval from transplantation to intervention was 348 days +/- 159. Mean follow-up was 678 days (range, 16-2880 days). Technical success did not result in clinical improvement in one patient. Biopsy demonstrated severe hepatic necrosis, likely from prolonged venous congestion, and the patient required repeat transplantation. Only one patient required reintervention for stent migration, and no other complications occurred. No significant restenosis was encountered after stent placement.
Hepatic venous outflow obstruction is an uncommon but potentially fatal complication of piggyback orthotopic liver transplantation. Endovascular treatment with balloon-expandable stents is effective, safe, and apparently durable.
回顾性评估背驮式原位肝移植术后肝静脉流出道梗阻的血管内治疗。
本研究在机构审查委员会的批准和指导下进行,并符合《健康保险流通与责任法案》。对于这项回顾性研究,机构审查委员会无需患者签署知情同意书。1995年至2003年,13例患者(8例男性,5例女性),包括12例成年人和1例青少年(年龄范围14 - 67岁;中位年龄52岁),接受了背驮式原位肝移植术后肝静脉流出道梗阻的血管内治疗。所有患者均签署了手术知情同意书。11例患者接受了全肝移植,2例接受了亲属活体供肝右肝叶移植。4例患者在介入治疗前接受了再次背驮式原位肝移植。12例患者进行了初次支架置入。1例患者拒绝初次支架置入,选择单纯静脉成形术,但5个月后需要置入支架。使用短的球囊扩张支架(平均直径14.6 mm ± 1.1 [标准差])以尽量减少分支血管的被覆盖并抵抗回缩。测量了术前和术后的压力梯度。随访包括静脉造影、横断面成像和实验室检查。采用Wilcoxon符号秩和检验或符号检验比较术前和术后的压力梯度、体重及实验室值。
13例患者中有13例获得技术成功(压力梯度≤3 mmHg),13例中有12例获得临床成功。术前和术后平均压力梯度分别为13.0 mmHg ± 1.4和0.8 mmHg ± 0.3。从移植到介入的平均间隔时间为348天±159天。平均随访时间为678天(范围16 - 2880天)。1例患者技术成功但临床症状未改善。活检显示严重肝坏死,可能因长期静脉淤血所致,该患者需要再次移植。仅1例患者因支架移位需要再次干预,未发生其他并发症。支架置入后未出现明显再狭窄。
肝静脉流出道梗阻是背驮式原位肝移植一种罕见但可能致命的并发症。球囊扩张支架血管内治疗有效、安全且效果持久。